SYRE vs TGTX Stock Comparison
TGTX currently leads SYRE in this stock comparison, with AIQ scores of 76 vs 64. The clearest difference is value.
What is the main difference between SYRE and TGTX?
TGTX leads the current stock comparison as TG Therapeutics, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Spyre Therapeutics, Inc. vs TG Therapeutics, Inc.
TGTX leads
TGTX leads by 12 AIQ points, primarily on Value and Momentum.
Stable: 5 of 5 evidence groups support TGTX, and its current signal state is conflicted.
Spyre Therapeutics, Inc.
TG Therapeutics, Inc.
The Algovestiq AIQ Score currently favors TGTX over SYRE, 76 versus 64 as of Nov 15, 2026. TGTX's advantage is driven primarily by stronger value and momentum. TGTX also shows the stronger technical structure relative to its 50-day moving average. 5 of 5 covered evidence groups favor TGTX today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. TGTX lead: Stable — the AIQ differential has held near 12 points over 30 sessions. TGTX leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.
Compare Spyre Therapeutics, Inc. and TG Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare SYRE and TGTX against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value44 vs 65TGTX +21
- Momentum81 vs 93TGTX +12
- Risk Resilience53 vs 63TGTX +10
- Quality61 vs 69TGTX +8
5 of 5 evidence groups favor TGTX. TGTX’s edge is concentrated in value and momentum.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +2
New signals
- ADX Trend Weakening — neutral, trend, medium horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.75x)
Largest factor move: Quality +1
No signal started or stopped since the prior session; its 8 active signals are unchanged.
TGTX's lead narrowed by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — SYRE and TGTX both carry a full feed there.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
TGTXTGTX on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
TGTXTGTX on combined revenue and EPS growth.
Value
TGTXTGTX on the peer-relative Value factor, by 21 points.
Momentum
TGTXTGTX on the Momentum factor, by 12 points.
Lower downside
TGTXTGTX on Risk Resilience, by 10 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | SYRE | TGTX | Note |
|---|---|---|---|
| Implied upside to target | +18.1% | — | Level |
| Target dispersion | +11.4% | — | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 18 | 8 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
5 of 5 covered evidence groups favor TGTX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | TGTX | 64 vs 76 |
| Fundamentals | TGTX | EPS growth -161.1% vs 6.1%; TTM ROE -9.1% vs 9.7%; gross margin 50% vs 82.7%; operating margin -276.5% vs 21.5% |
| Valuation | TGTX | Value 44 vs 65 |
| Technicals | TGTX | Price vs 50-day 13.7% vs 13.8%; vs 200-day 35.7% vs 42.2% |
| Risk Resilience | TGTX | Risk Resilience 53 vs 63 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of SYRE and TGTX and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 12 points. (supports the conclusion holding)
- 5 of 5 covered evidence groups point the same way. (supports the conclusion holding)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on TGTX.
How the comparison changed
120 daily snapshots · May 27 – Nov 13TGTX lead: Stable — the AIQ differential has held near 12 points over 30 sessions.
- Today
- TGTX +12
- 64 vs 76
- 7 sessions ago
- TGTX +12
- 62 vs 74
- 30 sessions ago
- TGTX +13
- 57 vs 70
- 90 sessions ago
- TGTX +2
- 69 vs 71
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 1 bearish / 2 neutral, conflicted
Only SYRE
- ADX Trend Weakening — neutral, trend, medium horizon
4 bullish / 2 bearish / 2 neutral, conflicted
Only TGTX
- ADX Trend Strengthening — neutral, trend, medium horizon
- RSI Bearish Divergence — bearish, momentum, medium horizon
Both carry 6 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode, EMA Ribbon Expansion Bullish, Low Volume Rally Warning, TRIX Bullish Signal, Uptrend Structure Active.
TGTX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +1.06%, AIQ +2 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.08%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1SYRE closes the Value gap — currently 21 points behind, the largest single contributor to TGTX's edge.
- 2SYRE's Low Volume Rally Warning resolves — a bearish volume rule currently active against it.
- 3TGTX's conflicting signal state resolves bearish — it currently carries 4 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
TGTX leads on balance| Metric | SYRE | TGTX |
|---|---|---|
| Revenue growth (YoY) | 0% | 8.2% |
| EPS growth (YoY) | -161.1% | 6.1% |
| Gross margin | 50% | 82.7% |
| Operating margin | -276.5% | 21.5% |
| Return on equity (TTM) | -9.1% | 9.7% |
| Debt to equity | 0 | 1.32 |
Performance
Split across windows| Metric | SYRE | TGTX |
|---|---|---|
| 1 week (5 sessions) | 0.1% | 7.8% |
| 1 month (20 sessions) | 30.2% | 19.5% |
| 3 months (63 sessions) | -0.6% | 30.9% |
| 6 months (126 sessions) | 38.8% | 63.3% |
| Year to date | 217.5% | 116.4% |
| 1 year (252 sessions) | 343.9% | 108% |
Technicals
TGTX has the stronger structure| Metric | SYRE | TGTX |
|---|---|---|
| RSI (14) | 59.4 | 65.4 |
| ADX (14) | 17.9 | 24 |
| Price vs 50-day | 13.7% | 13.8% |
| Price vs 200-day | 35.7% | 42.2% |
| Volatility (1M, annualized) | 59.5% | 43.3% |
Risk
TGTX is the more resilient| Metric | SYRE | TGTX |
|---|---|---|
| Beta | 1.69 | 0.68 |
| Sharpe ratio | 2.57 | 1.74 |
| Sortino ratio | 4.62 | 2.99 |
| Max drawdown | -27.8% | -21.8% |
| Current drawdown | -4.6% | -1.9% |
| Annualized volatility | 66.7% | 46.1% |
| Value at risk (95%) | -4.9% | -3.6% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, SYRE or TGTX?
On the Algovestiq AIQ Score, TGTX is the stronger of the two as of Nov 15, 2026, scoring 76 against SYRE's 64. The edge comes from value and momentum. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is SYRE or TGTX the better buy right now?
TGTX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 5 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor TGTX over SYRE?
The composite weights Quality, Value, Momentum and Risk Resilience. TGTX leads Value by 21 points; TGTX leads Momentum by 12 points; TGTX leads Risk Resilience by 10 points. TGTX leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by SYRE simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.
Which has more analyst upside, SYRE or TGTX?
Analyst price targets imply +18.1% upside for SYRE and not covered for TGTX. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, SYRE or TGTX?
TGTX is the better-valued of the two on the peer-relative Value factor. TGTX on the peer-relative Value factor, by 21 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, SYRE or TGTX?
TGTX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, SYRE or TGTX?
TGTX on the Momentum factor, by 12 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, SYRE or TGTX?
TGTX is the more resilient of the two, so the other name carries the higher downside risk. TGTX on Risk Resilience, by 10 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is SYRE more profitable than TGTX?
TGTX leads on the comparable margin measures — gross margin 50% vs 82.7%; operating margin -276.5% vs 21.5%; ttm roe -9.1% vs 9.7%.
Is TGTX's lead over SYRE getting stronger or weaker?
TGTX lead: Stable — the AIQ differential has held near 12 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the SYRE vs TGTX verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: SYRE closes the Value gap — currently 21 points behind, the largest single contributor to TGTX's edge; SYRE's Low Volume Rally Warning resolves — a bearish volume rule currently active against it; TGTX's conflicting signal state resolves bearish — it currently carries 4 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about SYRE and TGTX?
SYRE: 4 bullish / 1 bearish / 2 neutral, conflicted. TGTX: 4 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on SYRE is Golden Cross Active (bullish, long horizon). On TGTX it is Golden Cross Active (bullish, long horizon).
Compare SYRE and TGTX with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.